Synthesis and regulation of sex hormone-binding globulin in obesity

International Journal of Obesity

Volumn 24, Issue , 2000, Pages S64-S70

  Hautanen, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Androgens estrogens; Cortiso; Estradiol; HDL; Insulin; Testosterone

Indexed keywords

CORTICOTROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADRENAL GLANDS; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; C-PEPTIDE; CHOLESTEROL, HDL; FINLAND; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OBESITY; PITUITARY GLAND; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES;

EID: 0033913093     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801281     Document Type: Article

References (49)

1. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev 1990; 11: 80-91.
2. Bond A, Davis C. Sex hormone binding globulin in clinical perspective. Acta Obstet Gynecol Scand 1987; 66: 55-62.
3. Despres J-P, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 1994; 5: 274-289.
4. Hopkins PH, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Curr Opin Lipidol 1996; 7: 241-253.
5. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
6. Glass AR. Endocrine aspects of obesity. Med Clin N Am 1989; 73: 139-160.
7. Vermeulen A, Verdonk L, Van Der Straeten M, Orie N. Capacity of the testosterone-binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocr Metab 1969; 29: 1470-1480.
8. Glass AR, Sverdloff RS, Bray GA, Dahms WT, Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocr Metab 1977; 45: 1211-1219.
9. Kopelman PG, Pilkington TRE, White N, Jeffcoate SL. Abnormal sex steroid secretion and binding in massively obese women. Clin Endocr 1980; 12: 363-369.
10. Stefanick ML, Williams PT, Krauss RM, Terry RB, Vranizan KM, Wood PD. Relationships of plasma estradiol, testosterone and sex hormone-binding globulin with lipoproteins, apolipo-proteins, and high density lipoprotein subfractions in men. J Clin Endocr Metab 1987; 64: 723-729.
11. Hämälainen E, Adlercreutz H, Ehnholm C, Puska P. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. Metabolism 1986; 35: 535-541.
12. Semmens J, Rouse I, Beilin LJ, Masarei JRL. Relationship of plasma HDL-cholesterol to testosterone, estradiol and sex hormone-binding globulin levels in men and women. Metabolism 1983; 32: 428-432.
13. Haffner SM, Katz MS, Stern MP, Dunn JF. Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 1989; 9: 136-143.
14. Tchernof A, Labrie F, Belanger A, Prud’homme D, Bouchard C, Tremblay A, Nadeau A, Despres J-P. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis 1997; 133: 235-244.
15. Pugeat M, Moulin P, Cousin P, Fimbel S, Nicolas MH, Crave JC, Lejeune H. Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J Steroid Biochem Mol Biol 1995; 53: 1-6.
16. Peiris AN, Stagner JI, Plymate SR, Vogel RL, Heck M, Samols E. Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men. J Clin Endocr Metab 1993; 76: 279-282.
17. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study. J Clin Endocr Metab 1993; 76: 283-287.
18. Birkeland KI, Hanssen KF, Toijesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocr Metab 1993; 76: 275-278.
19. Bjärntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 291-302.
20. Hautanen A, Adlercreutz H. Pituitary-adrenocortical function in abdominal obesity of males: evidence for decreased 21-hydroxylase activity. J Steroid Biochem Mol Biol 1996; 58: 123-133.
21. Hautanen A, Räikkänen K, Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinemia and dyslipidemia in normotensive males. J Intern Med 1997; 241: 451-461.
22. Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med 1993; 234: 461-469.
23. Hautanen A, Mänttäri M, Manninen V, Huttunen JK, Frick MH, Adlercreutz H. Significance of adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis 1994; 105: 191-200.
24. Hautanen A, Adlercreutz H. Hyperinsulinaemia, dyslipidae-mia and exaggerated adrenal androgen response to adreno-corticotropin in male smokers. Diabetologia 1993; 36: 1275-1281.
25. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscl Thromb 1994; 14: 1940-1945.
26. Jaquish CE, Blangero J, Haffner SM, Stern MP, Maccluer JW. Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study. Metabolism 1997; 46: 988-991.
27. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 50(Suppl 201): 3-23.
28. Mercier-Bodard C, Baulieu E-E. Hormonal control of SBP in human hepatoma cells. J Steroid Biochem 1986; 24: 443-448.
29. Lee IR, Dawson SA, Wetherall JD, Hahnel R. Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens. J Clin Endocr Metab 1987; 64: 825-831.
30. Singh A, Hamilton-Fairley D, Koistinen R, Seppälä M, James VHT, Franks S, Reed MJ. Effect of insulin-like growth factortype I (IGF-I) and insulin on the secretion of sex hormone-binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 1990; 124: R1-R3.
31. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocr Metab 1988; 67: 460-464.
32. Maruyama Y, Aoki N, Suzuki Y, Sinohara H, Yamamoto T. Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay. Acta Endocr (Copenh.) 1984; 106: 428-432.
33. Loukovaara M, Carson M, Adlercreutz H. Regulation and production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocr Metab 1995; 80: 160-164.
34. White PC, Curnow KM, Pascoe L. Disorders of steroid 11ß-hydroxylase isoenzymes. Endocr Rev 1994; 15: 421-438.
35. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhytmicity and sleep in human glucose regulation. Endocr Rev 1997; 18: 716-738.
36. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965.
37. Márin P, Darin N, Amemiya T, Andersson B, Jern S, Bjärn-torp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882-886.
38. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns ofbody fat distribution. JClinEndocrMetab 1993; 77:341-346.
39. Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocr Metab 1997; 82: 2771-2776.
40. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocr Metab 1997; 82: 3647-3654.
41. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Pesponse of leptin to short-term and prolonged overfeeding in humans. J Clin Endocr Metab 1996; 81: 4162-4165.
42. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
43. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. J Clin Endocr Metab 1997; 82: 579-584.
44. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med 1997; 3: 575-579.
45. Licinio J, Negrao AB, Mantzoros C, Kaklamani V, Wong ML, Bongiorno PB, Mulla A, Cearnal L, Veldhuis JD, Flier JS, McCann SM, Gold PW. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci USA 1998; 95: 2541-2546.
46. Heiman ML, Ahima RS, Craft LS, Schoner P, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic ± pituitary ± adrenal axis in response to stress. Endocrinology 1997; 138: 3859-3863.
47. Licinio J. Longitudinally sampled human plasma leptin and cortisol concentrations are inversely correlated (letter). J Clin Endocr Metab 1998; 83: 1042.
48. Korbonits M, Trainer PJ, Little JA, Edwards R, Kopelman PG, Besser GM, Svec F, Grossman AB. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary ± adrenal activity. Clin Endocr 1997; 46: 751-757.
49. Bornstein SR, Uhlmann K, Haidan A, Ehrhart BM, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-1238.